Friday 14 June

Sponsored Breakfast Symposia

Venue: Shed 6 Room 4Time: 0745-0845hrs (breakfast served from 0730 – 0745hrs)Title: The ‘stable’ heart failure patient...and beyondSpeaker: Dr Pardeep Jhund, University of GlasgowChair: Assoc. Prof Gerry DevlinSynopsis: Despite evidence-based pharmacologic therapy, morbidity and mortality associated with HF-rEF remains high, leaving opportunity for further improvement in care.Annual mortality for HF is higher than that of some common cancers, additionally patients with stable NYHA Class II symptoms have underlying disease progression and are at high risk of sudden cardiac death.Patients hospitalised for heart failure have a 2.5 times increased risk of mortality and the mortality risk is doubled in the first 30 days. Hospitalisation provides an opportunity for HF optimisation.Dr Jhund will explore these topics, the latest research in HF treatment, and discuss how clinicians can change the course of HF for their patients.